Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New treatments, and better use of existing treatments, are essential to reduce ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

The Saskatchewan Cancer Agency (SCA) says it is working to ensure women in the province have access to breast cancer ...

Fairbanks Memorial Hospital is fundraising for a $6M PET scanner to improve cancer detection. Over $1.4M has been raised, ...

A study of depressed individuals found that an eight‐week treatment with selective serotonin reuptake inhibitors (SSRIs) ...

IMRIS, the US-based provider of interoperative magnetic resonance imaging (MRI) systems for use in operating theatres conducting advanced neurosurgery, has been acquired by private equity entity ...

The Society for Imaging Informatics in Medicine (SIIM) has done more than any other professional society to promote the ...

Imaging technology developed and refined at the University of Waterloo promises better detection and treatment of breast ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...